中国实用外科杂志 ›› 2010, Vol. 30 ›› Issue (10): 828-830.

• 专家论坛 • 上一篇    下一篇

遗传性甲状腺癌

陈    曦,李宏为   

  1. 上海交通大学医学院附属瑞金医院外科,上海200025
  • 出版日期:2010-10-01 发布日期:2010-09-28

  • Online:2010-10-01 Published:2010-09-28

摘要:

遗传性甲状腺癌分两大类:家族性非髓样甲状腺癌(FNMTC)和遗传性甲状腺髓样癌(HMTC)。前者可单独发生或仅作为某一家族性肿瘤综合征的少见部分,后者则可分为多发性内分泌肿瘤2a型(MEN-2a)、多发性内分泌肿瘤2b型(MEN-2b)和家族性甲状腺髓样癌(FMTC)。FNMTC由抑癌基因突变引起,外显率不高,但多为多发性病灶,较散发病例更具侵袭性,局部浸润常见,易早期转移,复发率高。而HMTC是一种由原癌基因RET突变所致的高外显率的单基因显性遗传性疾病。早期诊断很重要,通过基因测序可发现无症状病例,并依照基因突变类型,决定预防性全甲状腺切除手术时机。

关键词: 家族性非髓样甲状腺癌, 遗传性甲状腺髓样癌, 基因诊断

Abstract:

Hereditary thyroid cancer        CHEN Xi,LI Hong-wei. Department of Surgery, Ruijin Hospital of Shanghai Jiaotong University School of Medicine, Shanghai200025,China
Corresponding author:LI Hong-wei,E-mail:hwli@263.net
Abstract    Hereditary thyroid cancer includes familial nonmedullary thyroid cancer (FNMTC) and hereditary medullary thyroid cancer (HMTC). FNMTC may occur as a minor component of familial cancer syndromes or as a primary feature, with higher rates of multicentric tumors, lymph node metastasis, extrathyroidal invasion and shorter disease-free survival. A hereditary predisposition to nonmedullary thyroid cancer is well established, but the susceptibility genes for isolated FNMTC have not been identified. In the other hand, HMTC is a model of genetically determined cancer in which both diagnostic and therapeutic strategies rely on the identification of specific mutations. It may be observed with either multiple endocrine neoplasia syndromes 2A and 2B or as FMTC. The early diagnosis is especially important, and the genetic testing and direct DNA analysis allows the identification of asymptomatic patients. Surgical prophylaxis should be considered in the cases, ideally to prevent the development of MTC.

Key words: familial nonmedullary thyroid carcinoma, hereditary medullary thyroid cancer, genetic diagnosis